Lapatinib in combination with capecitabine versus continued use of trastuzumab in breast cancer pati...
Lapatinib in combination with capecitabine versus continued use of trastuzumab in breast cancer patients with trastuzumab-resistance: a retrospective study of a Chinese population
About this item
Full title
Author / Creator
Yang, Fan , Huang, Xiang , Sun, Chunxiao , Li, Jianbin , Wang, Biyun , Yan, Min , Jin, Feng , Wang, Haibo , Zhang, Jin , Fu, Peifen , Zeng, Tianyu , Wang, Jian , Li, Wei , Li, Yongfei , Yang, Mengzhu , Li, Jun , Wu, Hao , Fu, Ziyi , Yin, Yongmei and Jiang, Zefei
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
The efficacy and safety of lapatinib plus capecitabine (LC or LX) versus trastuzumab plus chemotherapy in patients with HER-positive metastatic breast cancer who are resistant to trastuzumab is unknown.
We retrospectively analyzed data from breast cancer patients who began treatment with regimens of lapatinib plus capecitabine (LC or LX) or tras...
Alternative Titles
Full title
Lapatinib in combination with capecitabine versus continued use of trastuzumab in breast cancer patients with trastuzumab-resistance: a retrospective study of a Chinese population
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_94e0c6dd6eeb433fb12a1ef24692a67c
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_94e0c6dd6eeb433fb12a1ef24692a67c
Other Identifiers
ISSN
1471-2407
E-ISSN
1471-2407
DOI
10.1186/s12885-020-6639-4
